Meet the people behind SunnyPharma’s medically reviewed health education.
SunnyPharma® publishes independent health education written by qualified medical writers and reviewed by clinicians with relevant subject-matter expertise. Our editorial system is built around accuracy, transparency, source quality, and patient usefulness.
Our editorial mission
Patients need medical information that is accurate enough for clinical topics and clear enough to use in real life. SunnyPharma’s editorial team focuses on medication access, treatment costs, drug safety, and evidence-based education for HIV, hepatitis C, and other high-cost treatment areas.
What this page is for
This page identifies the people and process behind SunnyPharma content. It supports transparency for readers, clinicians, search engines, and quality reviewers evaluating the trustworthiness of health information.
Editorial leadership
Editorial leadership manages content standards, source quality, reviewer coordination, readability, disclosure controls, and update workflows.
Stephanie Ritz, PhD
Medical Writer & Content Specialist
Stephanie Ritz writes and develops patient-facing medical content for SunnyPharma. Her work focuses on translating complex clinical and scientific information into clear, usable education for patients and caregivers.
Her background includes cancer biology, pharmaceutical-sector experience, medical writing, and health communication across treatment areas including HIV, hepatitis C, oncology, and medication access.
Editorial responsibilities
Content quality control
The editorial role exists to make sure each article has a clear reader purpose, strong source support, accurate attribution, and appropriate medical review before publication.
- Evidence and source verification
- Plain-language medical explanation
- Reviewer coordination
- Update and revision tracking
- Disclosure and policy alignment
Medical review team
Medical reviewers evaluate clinical claims, medication safety statements, drug interaction information, guideline consistency, and risk communication before content is published or updated.
Dr. Neha Mishra, MD
Medical Reviewer
Dr. Neha Mishra reviews SunnyPharma content involving HIV treatment, antiretroviral therapy, hepatitis C care, infectious disease pharmacology, and patient-facing medication safety topics.
Dr. Ranjit Mohan, MD
Medical Reviewer
Dr. Ranjit Mohan reviews content related to HIV treatment, internal medicine, infectious disease topics, antiretroviral pharmacology, medication safety, and patient education.
Reviewer standard
Clinical accuracy check
Reviewers check whether clinical statements are accurate, properly caveated, aligned with current evidence, and appropriate for a patient-facing audience.
- Medication accuracy
- Guideline consistency
- Risk and safety language
- Drug interaction review
- Source appropriateness
How our editorial process works
SunnyPharma uses a multi-step process for medical content. The goal is to reduce unsupported claims, improve patient comprehension, and keep clinically important information current.
Topic selection
Topics are selected based on patient need, medication access barriers, treatment cost questions, safety concerns, and gaps in existing health education.
Research and source review
Writers use high-quality sources such as prescribing information, clinical guidelines, public health agencies, regulatory documents, peer-reviewed literature, and official program information.
Editorial drafting
The writer converts technical medical information into clear, structured patient education while preserving clinical accuracy and avoiding unsupported claims.
Medical review
A qualified reviewer evaluates the article for clinical accuracy, medication safety, guideline alignment, and appropriate risk communication.
Publication and attribution
Published pages identify the writer, medical reviewer, review date, update date, and relevant editorial-policy links wherever appropriate.
Updates and corrections
Content is updated when new evidence, drug approvals, guideline changes, safety information, pricing data, or access-program details materially change the article.
How SunnyPharma supports E-E-A-T
For health content, trust depends on visible expertise, transparent sourcing, editorial accountability, and clear boundaries between education and medical advice.
Experience
SunnyPharma content is built around practical patient questions: medication cost, treatment access, side effects, insurance barriers, and what to discuss with a clinician.
Expertise
Medical topics are written by qualified health communicators and reviewed by clinicians or scientific experts with relevant subject-matter knowledge.
Authoritativeness
Articles rely on primary and high-quality sources, including regulatory labels, treatment guidelines, public health agencies, and peer-reviewed evidence.
Trustworthiness
SunnyPharma publishes editorial policies, reviewer pages, author pages, disclosure standards, and review/update information so readers can evaluate the content source.
Editorial independence and disclosures
SunnyPharma’s editorial conclusions are not controlled by pharmaceutical manufacturers, advertisers, pharmacies, or commercial sponsors. Content decisions are based on evidence quality, patient education value, and clinical relevance.
Medical advice boundary
SunnyPharma content is for education only. It does not replace diagnosis, treatment, or medical advice from a licensed healthcare professional. Patients should speak with their clinician before starting, stopping, or changing any medication.
Source standards
SunnyPharma gives preference to primary and institutionally reliable sources when reviewing medical content.
Regulatory sources
FDA prescribing information, drug labels, safety communications, approval documents, and official regulator updates.
Clinical guidelines
Guidance from recognized medical societies, public health agencies, and specialty organizations relevant to the article topic.
Peer-reviewed evidence
Clinical trials, systematic reviews, observational studies, pharmacology research, and published medical literature.
Last editorial page update: May 30, 2026. This page should be reviewed whenever SunnyPharma adds or removes medical reviewers, writers, or editorial policies.
